Header image

Concurrent Session 2C - Part 1: Prescribed Drugs | Part 2: Improving Service Users Experience & Engagement

Tracks
Track 3
Wednesday, October 30, 2024
3:30 PM - 5:00 PM
Menzies

Details

Chair: Kate Senior, DASSA


Speaker

Agenda Item Image
Prof Suzanne Nielsen
Professor And Deputy Director, Monash Addiction Research Centre
Monash University

An e-Delphi study to develop best-practices for opioid safety in community pharmacy settings

3:30 PM - 3:40 PM

Biography

Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is the Deputy Director of the Monash Addiction Research Centre at Monash University in Melbourne. She has been a registered pharmacist for over 20 years, with clinical experience in the treatment of substance use disorders in community pharmacy and specialist drug treatment settings.
Agenda Item Image
Ms Amy McNeilage
PhD Candidate
The University of Sydney

Lived experiences of nonmedical gabapentinoid use and symptoms of dependence: A systematic review of qualitative research

3:40 PM - 3:45 PM

Biography

Amy McNeilage is PhD Candidate and Senior Research Officer at The University of Sydney studying gabapentinoid-related harms. She has developed expertise in qualitative methodology and has demonstrated the quality of her research with publications in several leading journals, including IJDP, PAIN, & IJDP.
Agenda Item Image
Dr Ria Hopkins
Postdoctoral Research Fellow
National Drug And Alcohol Research Centre, UNSW Sydney

“We didn’t cause the opioid epidemic”: The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions.

3:45 PM - 3:55 PM

Biography

Dr Ria Hopkins is a Postdoctoral Research Fellow at the National Drug and Alcohol Research Centre, UNSW Sydney, examining patterns of medicine use and associated outcomes. She is interested in potentially high-risk medicines including opioid and psychotropic medicines, and priority populations including people living with pain or mental health conditions.
Dr Ting Xia
Research Fellow
Monash University

Geographic variation in gabapentinoid, opioid and physical therapies utilisation among injured workers with low back pain

3:55 PM - 4:00 PM

Biography

Dr Ting Xia is a Research Fellow with Monash Addiction Research Centre at Monash University with a focus on the use of linked primary health data and hospital data to evaluate the impact of policy changes on opioid prescribing.
Dr Hester Wilson
Phd Student And Doctor
Drug and Alcohol Services, South East Sydney Local Health District

General practitioner experiences diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in NSW, Australia, 2021–2023

4:00 PM - 4:10 PM

Biography

Dr Hester Wilson, FRACGP, FAChAM, is a GP, Clinical Director of Drug and Alcohol in Murrumbidgee Local Health District, Medical Advisor for South East Sydney Local Health District, chair of Addiction SIG in the RACGP, PhD candidate and conjoint senior lecturer at UNSW and Chief Addiction Medicine Specialist for NSW.
APSAD 2024

Session Q&A

4:10 PM - 4:20 PM

Biography

Ms Chloe Haynes
Phd Student/Research Assistant
University of Wollongong

A scoping review of women’s experiences of treatment for opioid use disorder through a person-centred care lens

4:20 PM - 4:25 PM

Biography

Ms. Haynes is a PhD Candidate at the University of Wollongong and is conducting research on women's experiences of treatment for opioid use disorder, particularly their experiences of person-centred care. She has been engaged in numerous other research projects through her work as a research assistant.
Ms Grace Shuttleworth
Clinical Research And Program Content Lead
Lives Lived Well

Enhancing consumer engagement through digital innovation in mental health and substance use services

4:25 PM - 4:30 PM

Biography

Grace Shuttleworth is a Clinical Psychologist, currently employed by Lives Lived Well as the Clinical Research and Program Content Lead. Grace has worked across residential, community, hospital and correctional facilities, providing support for substance use concerns. Past research has focused on the effective integration lived-experience approaches in clinical services.
Dr Shelley Walker
DECRA Research Fellow
National Drug Research Institute

“It felt like they were doing everything they could to find [drugs]”: Policing experiences of people who use drugs during the COVID-19 pandemic

4:30 PM - 4:40 PM

Biography

Shelley is a Research Fellow at the Melbourne office of the National Drug Research Institute. She is a recipient of an ARC Discovery Early Career Research Award about police custody and young people, and is passionate about social justice and human rights issues.
James Poole

Principles for collaborative partnerships with people with lived or living experience in research projects

4:40 PM - 4:45 PM

Biography

Agenda Item Image
Ms Anke van der Sterren
Deputy CEO
Alcohol Tobacco and Other Drug Association ACT

Principles for collaborative partnerships with people with lived or living experience in research projects

4:40 PM - 4:45 PM

Biography

Anke is the Deputy CEO at the Alcohol Tobacco and Other Drug Association ACT (ATODA). Anke is a social scientist with over 25 years’ experience in research and evaluation in the areas of alcohol and other drugs, tobacco, blood borne viruses and workforce development.
APSAD 2024

Session Q&A

4:45 PM - 5:00 PM

Biography


Chair

Agenda Item Image
Katherine Senior
Addiction Medicine Specialist
DASSA

loading